[1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9512121
SERIAL NO

14889092

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are [1,2,4]triazol[4,3-a]pyridine derivatives as shown in the general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, wherein the pharmaceutical composition is used as a therapeutic agent, and especially used as a c-Met inhibitor and an immunosuppressant. Each substituent in the general formula (I) is the same as that defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE LIANYUNGANG JIANGSU 222047

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Qi, Qingqing Jiangsu, CN 3 4
Wang, Haiyang Jiangsu, CN 44 104
Wu, Chenchen Jiangsu, CN 10 13
Zhao, Zhiming Jiangsu, CN 13 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00